At a glance
- Originator Yamanouchi
- Developer Nonindustrial source
- Class Anti-inflammatories; Antiasthmatics; Antithrombotics
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 12 Mar 1998 No-Development-Reported for Asthma in USA (Unknown route)